NCT00133705 2023-09-25
Trial of Mifepristone for Fibroids
University of Rochester
Phase 3 Completed
Clinical Trials
11 trialsNCT02012296 2022-07-13
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
University of Chicago
Phase 1/2 Completed
NCT02651844 2022-05-06
MIPRA
Hospital Provincial Magdalena V. de MartÃnez
Phase NA Completed
NCT01898312 2022-01-19
BRCA1/2 and Effect of Mifepristone on the Breast
Karolinska Institutet
Phase 2 Completed
NCT01493310 2018-09-12
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
University of Chicago
Phase 1 Completed
NCT02046421 2018-09-11
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 1 Completed
NCT00579475 2015-05-25
The Effect of Mifepristone on Uterine Fibroids and Breast Tissue
Karolinska Institutet
Phase 1 Completed
NCT00886873 2014-10-17
Mifemyo_2
Mediterranea Medica S. L.
Phase 2/3 Completed
NCT00505739 2012-07-30
Mifepristone for Patients With Endometrial Cancer and LGESS
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00140478 2009-12-09
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00712595 2009-04-23
Mifemyo
Mediterranea Medica S. L.
Phase 2/3 Completed